Frailty and Resiliency in Older Adults with Acute Myocardial Infarction
患有急性心肌梗塞的老年人的虚弱和恢复能力
基本信息
- 批准号:10653124
- 负责人:
- 金额:$ 18.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute myocardial infarctionAddressAdmission activityAdultAdvocateAgeAge YearsAnemiaAwardBackBenefits and RisksBindingBioinformaticsBiometryBlood VesselsBlood flowCapsicumCardiologyCardiovascular DiseasesCardiovascular systemCaringClinical TrialsClinical effectivenessCoronaryCoronary Artery BypassCoronary heart diseaseData CollectionDecision MakingDevelopmentDiseaseEducational workshopElderlyEnvironmentEpidemiologistEvaluationExperimental DesignsExposure toFoundationsFrail ElderlyGeriatricsGerontologyGoalsGrantGuidelinesHealthHeartHeterogeneityHigh PrevalenceHospitalizationHypoalbuminemiaImpaired cognitionImpairmentInstitutionInternistInterventionKnowledgeLaboratoriesLearningLower ExtremityMeasurementMeasuresMedicalMedical LibrariesMedicareMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethodsOffice ManagementOlder PopulationOperative Surgical ProceduresOutcomeOutcomes ResearchPatient AdmissionPatient-Focused OutcomesPatientsPhenotypePhysiciansPhysiologicalPopulationPrevalenceProceduresProcessProspective StudiesPublic Health SchoolsResearchResearch PersonnelResearch ProposalsResistanceResourcesRetrospective cohort studyRiskRoleSamplingSyndromeTestingTimeTraining ProgramsUnited StatesUnited States National Institutes of HealthUniversitiesVascularizationWorkadverse outcomeage effectbeneficiarycare outcomescareerclinical decision-makingclinical investigationcomparative effectivenessdesigndiagnostic accuracydiagnostic tooldisabilityeducation researchevidence baseexperiencefollow-upfrailtyhealth related quality of lifeimprovedindexingmeetingsmortalityolder patientpatient populationpercutaneous coronary interventionresilienceskillsstandard of carestressortargeted treatmenttreatment choicetreatment responseyoung adult
项目摘要
The purpose of this research is to support the development of Dr. Abdulla Damluji into an
independent investigator focused on studying geriatric syndromes during cardiovascular intervention.
The K23 award will allow the development of a fundamental skillset including: the design and methods for
analysis of interventions, understanding and proper application of frailty and resiliency assessments, designing
pilot prospective studies, and enhancing knowledge of geriatrics and gerontology. Skills will be obtained through
coursework, workshops, seminars, scientific meetings and mentored research. The overall goals are: 1) identify
a simple universal bedside frailty test for clinical decision-making and 2) become an NIH-investigator prepared
to conduct a clinical trial aimed to evaluate the comparative effectiveness of different treatments of acute
myocardial infarction (AMI) in a heterogenous population of older adults living with frailty and lack of resiliency.
Two thirds of all patients with cardiovascular disease (CVD) are older than 60 years of age, and >85% of
patients over age 85 years live with some form of CVD. Of those older patients admitted with acute AMI, a
majority experience frailty, a syndrome of decreased physiologic reserve and vulnerability to stressors.
Moreover, some of these frail patients lack physical resiliency, the ability to rebound back and recover from a
major health crisis. Critical “gaps in knowledge” in cardiovascular care for older adults, particularly those with
frailty and lack of resiliency, have been identified. These “gaps” need to be addressed in order to provide the
best possible care to a growing older patient population. This proposal examines the hypothesis that frailty
and resiliency influence the treatment choice and health outcome after AMI. Aim1 evaluates the
prevalence of frailty in U.S. among older AMI patients by treatment [percutaneous coronary intervention (PCI),
coronary artery bypass graft (CABG) surgery, or guideline-directed medical therapy (GDMT)] using the validated
claims-based frailty index. Aim 2 examines the role of frailty in treatment response to PCI and CABG. Aim 3
validates the diagnostic accuracy of a bedside 4-item frailty scale and assesses whether this diagnostic tool,
used in combination with resiliency measurements, can predict health outcomes at 1-year follow-up.
The institutional environments at both the Inova Heart and Vascular Institute (IHVI) and Johns Hopkins
University (JHU) are ideal for conducting cardiovascular outcomes research. The mentorship consists of leaders
with expertise directly relevant to the career goals of the applicant: Christopher M O’Connor, MD (IHVI; expert
in experimental design); Dr Wayne Batchelor (IHVI: interventional cardiologist); Jodi B Segal, MD, MPH (JHU:
internist/epidemiologist; expertise in clinical effectiveness), and Gary Gerstenblith (JHU: geriatric cardiology).
Resources at IHVI include bioinformatics laboratory, grant management office, and a state-of-the-art research
office. At JHU, resources include the Bloomberg School of Public Health, Graduate Training Program in Clinical
Investigation, JHU Pepper Center Biostatistical and Research Education Cores, and the Welch Medical Library.
这项研究的目的是支持 Abdulla Damluji 博士发展成为一名
独立研究者专注于研究心血管干预期间的老年综合征。
K23 奖项将允许开发基本技能,包括:
分析干预措施、理解和正确应用脆弱性和复原力评估、设计
试点前瞻性研究,并通过提高老年病学和老年学技能来获得知识。
课程作业、讲习班、研讨会、科学会议和指导研究的总体目标是:1) 确定。
用于临床决策的简单通用床边衰弱测试,以及 2) 成为 NIH 研究者
进行一项临床试验,旨在评估不同治疗方法的比较有效性
心肌梗死(AMI)发生在身体虚弱且缺乏弹性的异质老年人群中。
三分之二的心血管疾病 (CVD) 患者年龄超过 60 岁,并且超过 85%
85 岁以上患有某种形式的 CVD 的患者中,有 1 名因急性 AMI 入院的老年患者。
大多数人都会经历虚弱,这是一种生理储备减少和容易受到压力源影响的综合症。
此外,其中一些虚弱的患者缺乏身体弹性,缺乏从疾病中恢复过来的能力。
老年人,特别是患有心血管疾病的老年人的心血管护理存在严重的“知识差距”。
已经确定了脆弱性和缺乏弹性,这些“差距”需要得到解决,以便提供
该提案检验了虚弱的假设。
AMI 评估后,弹性会影响治疗选择和健康结果。
美国老年 AMI 患者因治疗而虚弱的患病率 [经皮冠状动脉介入治疗 (PCI)、
冠状动脉搭桥术(CABG)手术,或指南指导的药物治疗(GDMT)]使用经过验证的
基于索赔的虚弱指数检查了虚弱在 PCI 和 CABG 治疗反应中的作用。
验证床边 4 项衰弱量表的诊断准确性,并评估该诊断工具是否
与弹性测量结合使用,可以预测一年随访时的健康结果。
Inova 心脏和血管研究所 (IHVI) 和约翰·霍普金斯大学的机构环境
大学 (JHU) 是进行心血管结果研究的理想场所。导师由领导者组成。
具有与申请人职业目标直接相关的专业知识:Christopher M O’Connor,医学博士(IHVI;专家
实验设计);Wayne Batchelor 博士(IHVI:介入心脏病学家);Jodi B Segal,医学博士、公共卫生硕士(JHU:
内科医生/流行病学家;临床有效性方面的专业知识)和 Gary Gerstenblith(JHU:老年心脏病学)。
IHVI 的资源包括生物信息学实验室、拨款管理办公室和最先进的研究
在约翰霍普金斯大学办公室,资源包括彭博公共卫生学院的临床研究生培训计划。
调查、JHU Pepper 中心生物统计和研究教育核心以及韦尔奇医学图书馆。
项目成果
期刊论文数量(51)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Geriatric Cardiology: Coming of Age.
- DOI:10.1016/j.jacadv.2022.100070
- 发表时间:2022-08-01
- 期刊:
- 影响因子:0
- 作者:Goyal, Parag;Kwak, Min Ji;Fleg, Jerome L
- 通讯作者:Fleg, Jerome L
Influence of Race/Ethnicity and Sex on Coronary Stent Outcomes in Diabetic Patients.
种族/民族和性别对糖尿病患者冠状动脉支架结果的影响。
- DOI:10.1016/j.jscai.2023.101053
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Epps,Kelly;Goel,Ridhima;Mehran,Roxana;Kandzari,David;Damluji,Abdulla;Tehrani,Behnam;Sherwood,Matthew;Truesdell,Alexander;Davis,Scott;Wang,JohnC;Lopez,Mario;Singh,Sarabjeet;Underwood,Paul;Allocco,Dominic;Batchelor,Wayne
- 通讯作者:Batchelor,Wayne
At the Crossroad Between Skeletal and Cardiac Muscle Cells.
- DOI:10.1161/circulationaha.122.059935
- 发表时间:2022-06-14
- 期刊:
- 影响因子:37.8
- 作者:deFilippi, Christopher R.;Damluji, Abdulla A.
- 通讯作者:Damluji, Abdulla A.
Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories.
- DOI:10.2174/1573403x17666211125090929
- 发表时间:2022
- 期刊:
- 影响因子:1.9
- 作者:Tehrani, Behnam N.;Damluji, Abdulla A.;Batchelor, Wayne B.
- 通讯作者:Batchelor, Wayne B.
Specificity of administrative coding for older adults with acute heart failure hospitalizations.
- DOI:10.1016/j.ahj.2020.02.004
- 发表时间:2020-05
- 期刊:
- 影响因子:4.8
- 作者:Cooper LB;Psotka MA;Sinha S;Nallamothu BK;deFilippi CR;Batchelor W;O'Connor CM;Damluji AA
- 通讯作者:Damluji AA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abdulla Al Damluji其他文献
Abdulla Al Damluji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abdulla Al Damluji', 18)}}的其他基金
Frailty and Resiliency in Older Adults with Acute Myocardial Infarction
患有急性心肌梗塞的老年人的虚弱和恢复能力
- 批准号:
10216336 - 财政年份:2020
- 资助金额:
$ 18.31万 - 项目类别:
Frailty and Resiliency in Older Adults with Acute Myocardial Infarction
患有急性心肌梗塞的老年人的虚弱和恢复能力
- 批准号:
10447588 - 财政年份:2020
- 资助金额:
$ 18.31万 - 项目类别:
Frailty and Resiliency in Older Adults with Acute Myocardial Infarction
患有急性心肌梗塞的老年人的虚弱和恢复能力
- 批准号:
10039640 - 财政年份:2020
- 资助金额:
$ 18.31万 - 项目类别:
相似国自然基金
FTO介导的m6A修饰调控Treg细胞衰老在老年急性心肌梗死后心室重塑中的作用及机制研究
- 批准号:82300335
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雅解毫命通过“肝-心轴”调控PI3K-Akt通路减轻急性心肌梗死的作用及机制研究
- 批准号:82360839
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Trim28调控ALDH2翻译后修饰在急性心肌梗死中的作用及机制
- 批准号:
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:
ALOX5-5-HETE介导铁死亡在急性心肌梗死残余炎症的机制研究
- 批准号:82300373
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多重急性心肌梗死生物标志物现场快速检测的干式免疫闭合式双极电化学发光传感技术的研究
- 批准号:32371554
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Long-term exposure to arsenic, and the co-occurrence of uranium, in public and private drinking water: associations with cardiovascular and chronic kidney diseases in the California Teachers Study
公共和私人饮用水中长期接触砷以及同时存在铀:加州教师研究中与心血管和慢性肾脏疾病的关联
- 批准号:
10677410 - 财政年份:2023
- 资助金额:
$ 18.31万 - 项目类别:
3D Bioprinting of a Bioelectric Cell Bridge for Re-engineering Cardiac Conduction
用于重新设计心脏传导的生物电细胞桥的 3D 生物打印
- 批准号:
10753836 - 财政年份:2023
- 资助金额:
$ 18.31万 - 项目类别:
Mindfulness and Behavior Change to Reduce Cardiovascular Disease Risk in Older People with HIV
正念和行为改变可降低老年艾滋病毒感染者的心血管疾病风险
- 批准号:
10762220 - 财政年份:2023
- 资助金额:
$ 18.31万 - 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:
10712202 - 财政年份:2023
- 资助金额:
$ 18.31万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 18.31万 - 项目类别: